Search
for
Sort by
Research 541–570 of 1000+
- Prevalence of polycystic ovaries in women with androgenic alopecia
- Androgen excess: Investigations and management
- Intracrinology and The Skin
- Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome
- Safety of testosterone treatment in postmenopausal women
- Side-Effects of Spironolactone Therapy in the Hirsute Woman
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Spironolactone is an Effective and Well Tolerated Systemic Antiandrogen Therapy for Hirsute Women*
- Diagnosis of hyperandrogenism: Biochemical criteria
- Androgenetic alopecia in men and women
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Insulin Resistance and Skin Diseases
- PCOS in adolescents
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors
- The SAHA Syndrome
- Mood and Sexual Function in Polycystic Ovary Syndrome
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- Dermatology of androgen-related disorders
- Familial Cortisol Resistance: Differential Diagnostic and Therapeutic Aspects
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Dienogest
- PHYSIOLOGIC SKIN CHANGES ASSOCIATED WITH PREGNANCY
- How should postmenopausal androgen excess be evaluated?
- Diagnostic criteria for PCOS: Is there a need for a rethink?
- Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families
- Anxiety, Depression, and Quality of Life in Women with Polycystic Ovarian Syndrome
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?